BRPI0414700A - 6-[(substituìdo)fenil]triazolopirimidinas como agentes anti-cáncer - Google Patents
6-[(substituìdo)fenil]triazolopirimidinas como agentes anti-cáncerInfo
- Publication number
- BRPI0414700A BRPI0414700A BRPI0414700-6A BRPI0414700A BRPI0414700A BR PI0414700 A BRPI0414700 A BR PI0414700A BR PI0414700 A BRPI0414700 A BR PI0414700A BR PI0414700 A BRPI0414700 A BR PI0414700A
- Authority
- BR
- Brazil
- Prior art keywords
- mammal
- compounds
- treating
- pharmaceutically acceptable
- acceptable salts
- Prior art date
Links
- 239000002246 antineoplastic agent Substances 0.000 title abstract 3
- -1 6 - [(substituted) phenyl] triazolopyrimidines Chemical class 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 abstract 6
- 206010028980 Neoplasm Diseases 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 4
- 206010048723 Multiple-drug resistance Diseases 0.000 abstract 3
- 230000010261 cell growth Effects 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000029115 microtubule polymerization Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"6-¢(SUBSTITUìDO)FENIL!TRIAZOLOPIRIMIDINAS COMO AGENTES ANTI-CáNCER". A presente invenção refere-se a alguns compostos de 6-¢(substituído) fenil!triazolopirimidina ou sais farmaceuticamente aceitáveis dos mesmos, e composições contendo os referidos compostos ou sais farmaceuticamente aceitáveis dos mesmos, em que referidos compostos são agentes anticâncer utilizáveis para o tratamento de câncer em mamíferos. A presente invenção ainda refere-se a um método de tratamento ou inibição do crescimento de células de tumores cancerosos e doenças associadas em um mamífero e ainda provê um método para o tratamento ou prevenção de tumores cancerosos que expressam resistência a drogas múltiplas (MDR) ou são resistentes devido a MDR, em um mamífero em necessidade do mesmo, cujo método compreende a administração ao referido mamífero de uma quantidade eficaz de referidos compostos ou sais farmaceuticamente dos mesmos. A presente invenção refere-se a um método de tratamento ou inibição do crescimento de células de tumores cancerosos e doenças associadas em um mamífero em necessidade do mesmo por promoção da polimerização de microtúbulos que compreende a administração ao referido mamífero de uma quantidade eficaz de referidos compostos e sais farmaceuticamente aceitáveis dos mesmos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50554403P | 2003-09-24 | 2003-09-24 | |
| PCT/US2004/030515 WO2005030775A1 (en) | 2003-09-24 | 2004-09-17 | 6-[(substituted)phenyl]triazolopyrimidines as anticancer agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0414700A true BRPI0414700A (pt) | 2006-11-14 |
Family
ID=34393032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0414700-6A BRPI0414700A (pt) | 2003-09-24 | 2004-09-17 | 6-[(substituìdo)fenil]triazolopirimidinas como agentes anti-cáncer |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US7507739B2 (pt) |
| EP (1) | EP1680425B1 (pt) |
| JP (1) | JP2007506744A (pt) |
| KR (1) | KR20060098368A (pt) |
| CN (1) | CN100519559C (pt) |
| AR (1) | AR045810A1 (pt) |
| AU (1) | AU2004276240A1 (pt) |
| BR (1) | BRPI0414700A (pt) |
| CA (1) | CA2539252A1 (pt) |
| CO (1) | CO5690598A2 (pt) |
| CR (1) | CR8288A (pt) |
| CY (1) | CY1106392T1 (pt) |
| DE (1) | DE602004004295T8 (pt) |
| DK (1) | DK1680425T3 (pt) |
| EC (1) | ECSP066458A (pt) |
| ES (1) | ES2279452T3 (pt) |
| GT (1) | GT200400190A (pt) |
| IL (1) | IL174281A0 (pt) |
| MX (1) | MXPA06003206A (pt) |
| NO (1) | NO20061318L (pt) |
| PA (1) | PA8613301A1 (pt) |
| PE (1) | PE20050433A1 (pt) |
| PL (1) | PL1680425T3 (pt) |
| PT (1) | PT1680425E (pt) |
| RU (1) | RU2006107579A (pt) |
| SA (1) | SA04250302A (pt) |
| SI (1) | SI1680425T1 (pt) |
| TW (1) | TW200512211A (pt) |
| WO (1) | WO2005030775A1 (pt) |
| ZA (1) | ZA200602387B (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6255309B1 (en) * | 1999-03-19 | 2001-07-03 | American Cyanomid Co. | Fungicidal trifluoromethylalkylamino-triazolopyrimidines |
| GEP20053688B (en) * | 2000-06-30 | 2005-12-12 | Wyeth Corp | Substituted-Triazolopyrimidines as Anticancer Agents |
| ES2279452T3 (es) | 2003-09-24 | 2007-08-16 | Wyeth Holdings Corporation | 6-((sustituido)fenil)triazolopirimidinas como agentes antineoplasicos. |
| US7419982B2 (en) * | 2003-09-24 | 2008-09-02 | Wyeth Holdings Corporation | Crystalline forms of 5-chloro-6-{2,6-difluoro-4-[3-(methylamino)propoxy]phenyl}-N-[(1S)-2,2,2-trifluoro-1-methylethyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine salts |
| MY179926A (en) * | 2003-12-08 | 2020-11-19 | Wyeth Corp | Process for the preparation of tubulin inhibitors |
| MX2007015718A (es) * | 2005-06-13 | 2008-02-21 | Wyeth Corp | Inhibidor de tubulina y proceso para su preparacion. |
| CN101193884A (zh) | 2005-06-13 | 2008-06-04 | 惠氏公司 | 微管蛋白抑制剂和其制备方法 |
| WO2007000412A1 (de) * | 2005-06-27 | 2007-01-04 | Basf Aktiengesellschaft | Verfahren zur herstellung von substituierten phenylmalonestern, zwischenverbindungen sowie deren verwendung zur herstellung von 5 , 7-dihydr0xy-6- (2,4, 6-trifluorphenyl) -(1,2 , 4) triazolo (1 , 5-a) pyrimidinen |
| WO2007075465A1 (en) * | 2005-12-16 | 2007-07-05 | Wyeth | Dimers and adducts of 6-[(substituted) phenyl] triazolopyrimidines useful as anticancer agents |
| TW200730530A (en) * | 2005-12-16 | 2007-08-16 | Wyeth Corp | Lyophilized compositions of a triazolopyrimidine compound |
| CN101600350A (zh) * | 2007-01-08 | 2009-12-09 | 巴斯夫欧洲公司 | 唑并嘧啶在防治植物病原性有害真菌中的用途 |
| US9649317B2 (en) | 2012-09-19 | 2017-05-16 | The Trustees Of The University Of Pennsylvania | Heterocyclic compounds and their use for the treatment of neurodegenerative tauopathies |
| US11623927B2 (en) | 2018-03-02 | 2023-04-11 | The Trustees Of The University Of Pennsylvania | Substituted [1,2,4]triazolo[1,5-a]pyrimidines for stabilizing microtubules |
| JP7646140B2 (ja) * | 2020-04-14 | 2025-03-17 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 置換された｛１，２，４，｝トリアゾロ｛１，５－ａ｝ピリミジン化合物および微小管の安定化におけるその使用 |
| CN114369098B (zh) * | 2022-01-06 | 2023-03-10 | 苏州大学 | 一种三唑并嘧啶醇类化合物及其制备方法和应用 |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW224044B (pt) | 1991-12-30 | 1994-05-21 | Shell Internat Res Schappej B V | |
| US5593996A (en) * | 1991-12-30 | 1997-01-14 | American Cyanamid Company | Triazolopyrimidine derivatives |
| JP2794510B2 (ja) | 1992-03-27 | 1998-09-10 | 富士写真フイルム株式会社 | ハロゲン化銀写真感光材料 |
| IL108731A (en) | 1993-03-04 | 1997-03-18 | Shell Int Research | 6, N-DISUBSTITUTED-£1, 2, 4| TRIAZOLO-£1, 5-a| PYRIMIDINE- 7-AMINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS FUNGICIDES |
| IL108747A (en) | 1993-03-04 | 1999-03-12 | Shell Int Research | Mushroom-killing preparations containing a history of 6 metamorphoses of 5 - 7 Dihalo - 1, 2 - 4 Triazlo [A-1,5] Pyrimidine Certain such new compounds and their preparation |
| RU2147584C1 (ru) | 1995-10-27 | 2000-04-20 | Американ Цианамид Компани | Способ получения дигалоидазолопиримидинов и способ получения дигидроксиазолопиримидинов |
| US5817663A (en) | 1996-10-07 | 1998-10-06 | American Cyanamid Company | Pentafluorophenylazolopyrimidines |
| US5750766A (en) | 1997-03-18 | 1998-05-12 | American Cyanamid Company | Process for the preparation of arylmalonates |
| EP0984919B1 (en) | 1997-03-18 | 2003-01-22 | Basf Aktiengesellschaft | Process for the preparation of arylmalonates |
| TWI252231B (en) | 1997-04-14 | 2006-04-01 | American Cyanamid Co | Fungicidal trifluorophenyl-triazolopyrimidines |
| US6117876A (en) | 1997-04-14 | 2000-09-12 | American Cyanamid Company | Fungicidal trifluorophenyl-triazolopyrimidines |
| US5948783A (en) | 1997-04-14 | 1999-09-07 | American Cyanamid Company | Fungicidal trifluoromethylalkylamino-triazolopyrimidines |
| US6255309B1 (en) | 1999-03-19 | 2001-07-03 | American Cyanomid Co. | Fungicidal trifluoromethylalkylamino-triazolopyrimidines |
| TW460476B (en) | 1997-04-14 | 2001-10-21 | American Cyanamid Co | Fungicidal trifluoromethylalkylamino-triazolopyrimidines |
| US5994360A (en) | 1997-07-14 | 1999-11-30 | American Cyanamid Company | Fungicidal 5-alkyl-triazolopyrimidines |
| US6020338A (en) | 1998-02-11 | 2000-02-01 | American Cyanamid Company | Fungicidal 7-alkyl-triazolopyrimidines |
| NZ506247A (en) | 1998-02-11 | 2003-03-28 | American Cyanamid Co | Fungicidal 7-(alkyl, alkenyl, alkadienyl, cycloalkyl, cycloalkenyl or aryl)-[1,2,4]triazolo[1,5-a]pyrimidines |
| US6124301A (en) | 1998-03-17 | 2000-09-26 | American Cyanamid Company | Enhancement of the efficacy of triazolopyrimidines |
| JPH11322517A (ja) | 1998-03-17 | 1999-11-24 | American Cyanamid Co | トリアゾロピリミジン類の効力の増進 |
| US5981534A (en) | 1998-09-25 | 1999-11-09 | American Cyanamid Company | Fungicidal 6-(2,6-difluoro-4-alkoxyphenyl)-triazolopyrimidines |
| US6284762B1 (en) | 1998-03-23 | 2001-09-04 | American Cyanamid Company | Fungicidal 6-(2-halo-4-alkoxyphenyl)-triazolopyrimidines |
| DE69926119T2 (de) | 1998-03-23 | 2005-12-29 | Basf Ag | Fungizide 6-(2-halo-4-alkoxyphenyl)-triazolopyrimidine |
| US6117865A (en) | 1998-09-10 | 2000-09-12 | American Cyanamid Company | Fungicidal trifluorophenyl-triazolopyrimidines |
| US6268371B1 (en) | 1998-09-10 | 2001-07-31 | American Cyanamid Co. | Fungicidal mixtures |
| JP2000103790A (ja) | 1998-09-25 | 2000-04-11 | American Cyanamid Co | 殺菌・殺カビ性のトリハロフェニル―トリアゾロピリミジン類 |
| US6242451B1 (en) | 1998-09-25 | 2001-06-05 | Klaus-Juergen Pees | Fungicidal trihalophenyl-triazolopyrimidines |
| US6277856B1 (en) | 1998-09-25 | 2001-08-21 | American Cynamid Co. | Fungicidal mixtures |
| ATE240648T1 (de) | 1998-09-25 | 2003-06-15 | Basf Ag | Fungizide mischungen |
| SK3662001A3 (en) | 1998-09-25 | 2001-11-06 | Basf Ag | Non-aqueous suspension concentrate |
| US5985883A (en) | 1998-09-25 | 1999-11-16 | American Cyanamid Company | Fungicidal trichlorophenyl-triazolopyrimidines |
| US5986135A (en) | 1998-09-25 | 1999-11-16 | American Cyanamid Company | Fungicidal trifluoromethylalkylamino-triazolopyrimidines |
| US6521628B1 (en) | 1999-01-29 | 2003-02-18 | Basf Aktiengesellschaft | Fungicidal mixtures |
| US6699874B2 (en) | 1999-09-24 | 2004-03-02 | Basf Aktiengesellschaft | Fungicidal mixtures |
| AU3154601A (en) | 1999-11-18 | 2001-05-30 | Basf Aktiengesellschaft | Non-aqueous concentrated spreading oil composition |
| US6559151B2 (en) | 2000-05-08 | 2003-05-06 | Basf Aktiengesellschaft | 6-(2-trifluoromethyl-phenyl)-triazolopyrimidines |
| GEP20053688B (en) * | 2000-06-30 | 2005-12-12 | Wyeth Corp | Substituted-Triazolopyrimidines as Anticancer Agents |
| AU1495802A (en) | 2000-08-25 | 2002-03-04 | Basf Ag | Fungicidal formulation |
| US6459602B1 (en) * | 2000-10-26 | 2002-10-01 | O2 Micro International Limited | DC-to-DC converter with improved transient response |
| JP2004513170A (ja) | 2000-11-13 | 2004-04-30 | ビーエーエスエフ アクチェンゲゼルシャフト | ７−（ｒ）−アミノトリアゾロピリミジン類、それらの製造及び植物病原性真菌を防除するためのそれらの使用 |
| DK1341794T3 (da) | 2000-12-06 | 2004-12-06 | Wyeth Corp | Fungicide 6-(2-trifluormethyl-phenyl)-triazolopyrimidiner |
| DE10063115A1 (de) | 2000-12-18 | 2002-06-27 | Bayer Ag | Triazolopyrimidine |
| WO2002067679A1 (en) | 2001-02-19 | 2002-09-06 | Basf Aktiengesellschaft | Fungicidal mixtures |
| PL367107A1 (en) | 2001-04-11 | 2005-02-21 | Basf Aktiengesellschaft | 5-halogen-6-phenyl-7-fluoroalkylamino-triazolopyrimidines as fungicides |
| DE10124208A1 (de) | 2001-05-18 | 2002-11-21 | Bayer Ag | Verwendung von Triazolopyrimidin-Derivaten als Mikrobizide |
| WO2003008416A1 (en) | 2001-07-18 | 2003-01-30 | Basf Aktiengesellschaft | Substituted 6-(2-methoxyphenyl) triazolopyrimides as fungicides |
| ES2279452T3 (es) | 2003-09-24 | 2007-08-16 | Wyeth Holdings Corporation | 6-((sustituido)fenil)triazolopirimidinas como agentes antineoplasicos. |
-
2004
- 2004-09-17 ES ES04788820T patent/ES2279452T3/es not_active Expired - Lifetime
- 2004-09-17 EP EP04788820A patent/EP1680425B1/en not_active Expired - Lifetime
- 2004-09-17 CA CA002539252A patent/CA2539252A1/en not_active Abandoned
- 2004-09-17 PL PL04788820T patent/PL1680425T3/pl unknown
- 2004-09-17 CN CNB2004800302006A patent/CN100519559C/zh not_active Expired - Fee Related
- 2004-09-17 MX MXPA06003206A patent/MXPA06003206A/es active IP Right Grant
- 2004-09-17 AU AU2004276240A patent/AU2004276240A1/en not_active Withdrawn
- 2004-09-17 DE DE602004004295T patent/DE602004004295T8/de active Active
- 2004-09-17 JP JP2006528075A patent/JP2007506744A/ja not_active Withdrawn
- 2004-09-17 BR BRPI0414700-6A patent/BRPI0414700A/pt not_active IP Right Cessation
- 2004-09-17 WO PCT/US2004/030515 patent/WO2005030775A1/en not_active Ceased
- 2004-09-17 KR KR1020067005785A patent/KR20060098368A/ko not_active Withdrawn
- 2004-09-17 RU RU2006107579/04A patent/RU2006107579A/ru not_active Application Discontinuation
- 2004-09-17 SI SI200430195T patent/SI1680425T1/sl unknown
- 2004-09-17 PT PT04788820T patent/PT1680425E/pt unknown
- 2004-09-17 DK DK04788820T patent/DK1680425T3/da active
- 2004-09-21 TW TW093128500A patent/TW200512211A/zh unknown
- 2004-09-22 SA SA04250302A patent/SA04250302A/ar unknown
- 2004-09-23 AR ARP040103440A patent/AR045810A1/es not_active Application Discontinuation
- 2004-09-23 PE PE2004000925A patent/PE20050433A1/es not_active Application Discontinuation
- 2004-09-24 GT GT200400190A patent/GT200400190A/es unknown
- 2004-09-24 PA PA20048613301A patent/PA8613301A1/es unknown
- 2004-09-24 US US10/950,543 patent/US7507739B2/en not_active Expired - Fee Related
-
2006
- 2006-03-13 IL IL174281A patent/IL174281A0/en unknown
- 2006-03-14 CR CR8288A patent/CR8288A/es not_active Application Discontinuation
- 2006-03-23 NO NO20061318A patent/NO20061318L/no not_active Application Discontinuation
- 2006-03-23 ZA ZA200602387A patent/ZA200602387B/xx unknown
- 2006-03-24 EC EC2006006458A patent/ECSP066458A/es unknown
- 2006-04-21 CO CO06038133A patent/CO5690598A2/es not_active Application Discontinuation
-
2007
- 2007-03-16 CY CY20071100373T patent/CY1106392T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0414700A (pt) | 6-[(substituìdo)fenil]triazolopirimidinas como agentes anti-cáncer | |
| BRPI0408005A (pt) | composto, composição farmacêutica, métodos para inibir angiogênese, atividade de pde4 em uma célula e proliferação de célula de cáncer, para inibir ou reduzir polimerização de tubulina ou estabilidade de tubulina em uma célula, para tratar ou melhorar um distúrbio inflamatório, um cáncer e um distúrbio do sistema nervoso central e para visar, bloquear ou destruir a função de vasculatura de tumor e o endotélio de vasos de tumor | |
| MX383644B (es) | Combinaciones y metodos de administracion de agentes terapeuticos y terapia de combinacion. | |
| BRPI0416656A (pt) | compostos de pirrolopirimidina úteis no tratamento do cáncer | |
| BRPI0513836A (pt) | composto, métodos de tratar, controlar ou prevenir cáncer, uma doença associada com angiogênese indesejada, e uma doença ou distúrbio mediado por pde 4, e de reduzir ou inibir o nìvel ou a atividade de pde 4 em um paciente, e, composição farmacêutica | |
| BRPI0413580A (pt) | composto, composição farmacêutica, e, métodos para tratar ou prevenir cáncer em um mamìfero em necessidade de tal tratamento, para modular a formação do fuso mitótico e para inibir a cinesina mitótica ksp | |
| BRPI0518315B8 (pt) | compostos de tiazol que modulam a atividade da proteína hsp90, métodos de inibição, tratamento e indução associados e composição farmacêutica | |
| RU2010137032A (ru) | Конъюгаты паклитаксела с полимером и способы лечения рака | |
| BRPI0414736A (pt) | 5-aril-pirimidinas como agentes anticáncer | |
| MX361467B (es) | Compuestos de isoindolina para uso en el tratamiento de cancer. | |
| BRPI0411098A (pt) | benzofuranocarboxamidas, com atividade pi3k, como agentes terapêuticos | |
| BRPI0414908A (pt) | compostos de benzazóis substituìdos, composições e métodos de inibição da atividade raf quinase em um humano ou animal | |
| BR0112038A (pt) | Triazolopirimidinas substituìdas como agentes anticâncer | |
| BRPI0511139A (pt) | compostos, composição farmacêutica que compreende os mesmos, método para inibir atividade de quinase aurora em uma célula e método para tratamento de um distúrbio mediado por quinase aurora em um paciente | |
| PT2484365E (pt) | Composições e métodos para o tratamento de doenças neovasculares | |
| CU20100062A7 (es) | Derivados de pirrolo [2,3-d] pirimidina como inhibidores de proteínas quinasas b | |
| BR0115109A (pt) | Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese | |
| BRPI0512075A (pt) | composto, processo para a preparação do mesmo, composição farmacêutica, uso de um composto, e, métodos para a produção de um efeito inibidor de b-raf, e de um efeito anticáncer em um animal de sangue quente, e para o tratamento de uma doença | |
| BRPI0905687A8 (pt) | composto da fórmula i ou i', composição farmacêutica, método de tratamento de um paciente com uma doença, uso do composto | |
| BR112012008325A2 (pt) | N-4 ( - ( ( 3- ( 2 - amino-4 pirimidinil) -2 -piridinil) oxi) fenil) -4- (4-metil-2-tienil) -1- ftalazinamina para uso no tratamento de câncer resistente a agente antimitótico | |
| BRPI0409926A (pt) | saposina c-dops: um agente antitumor | |
| BR9908125A (pt) | Composto, composto dimérico, composição farmacêutica, uso do composto, processo compreendendo inibir células de câncer, e, processo terapêutico | |
| BRPI0413384A (pt) | inibidores da proteìna farnesil transferase como agentes antitumores | |
| BRPI0715609A2 (pt) | Composto, uso de um composto, métodos para produzir um efeito antiproliferativo em um animal de sangue quente, e para tratar uma doença em um animal de sangue quente, e, composição farmacêutica | |
| BRPI0410875A (pt) | método de inibição do crescimento de tumor com anticorpos de fator antitecido |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |